Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis.
Leon NshimyumukizaJ A BeaumontF RousseauD ReinharzPublished in: Cost effectiveness and resource allocation : C/E (2020)
Introducing NIPT as a contingent test in the Quebec Trisomy 21 screening program is an affordable strategy compared to the current practice. Further research is needed to confirm if our results can be reproduced in other healthcare jurisdictions.